Stay updated on Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new site revision (v3.3.4) was added, replacing the previous revision (v3.3.3). This change affects page metadata and does not modify trial data, status, or details.
    Difference
    0.1%
    Check dated 2026-01-14T01:52:53.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The changes consist of adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T17:33:45.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; the update appears to be a platform/UI change with no changes to the study records or history data.
    Difference
    0.1%
    Check dated 2025-11-24T16:58:42.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Removed the government funding and operating status notice from the page.
    Difference
    0.5%
    Check dated 2025-11-17T15:03:41.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    A new history entry dated 2025-01-27 was added to the Record History. No substantive changes to the study record content, statuses, or data were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T01:34:13.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Major update: adds a government funding and operating status notice and marks the page as revision v3.2.0, replacing v3.1.0.
    Difference
    11%
    Check dated 2025-10-05T12:52:01.000Z thumbnail image

Stay in the know with updates to Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.